Treatment of patients with clinically lymph node-negative Squamous cell carcinoma of the oral cavity

Japanese Journal of Clinical Oncology

Volumn 38, Issue 6, 2008, Pages 395-401

  Jang, Won I I ^a   Wu, Hong Gyun ^a,c   Park, Charn I I ^a,c   Kim, Kwang Hyun ^a   Sung, Myoung Whun ^a   Kim, Myung Jin ^b   Choung, Pill Hoon ^b   Lee, Jong Ho ^b   Choi, Jin Yong ^b  

^a Seoul National University College of Medicine   (South Korea)

^b School of Dentistry   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Lymph node negative; Oral cavity cancer; Radio therapy; Squamous cell carcinoma; Surgery

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK DISSECTION; NECK METASTASIS; ORAL SURGERY; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; ADJUVANT THERAPY; CANCER STAGING; METASTASIS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; RISK FACTOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 46349110941     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn048     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Funk GF, Karrell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: A National Cancer Data Base report. Head Neck 2002;24:165-80.
3. Ho CM, Lam KH, Wei WI, Lau SK, Lam LK. Occult lymph node metastisis in simll oral tongue cancers. Head Neck 1992;14:359-63.
4. Kowalski LP, Bagietto R, Lara JR, Santos RL, Silva JF, Magrin J. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 2000;22:207-14.
5. Keski-Säntti H, Atula T, Törnwall J, Koivunen P, Mäkitic A. Elective neck treatment versus observation in patients with T1/T2 NO squamous cell carcinoma of oral tongue. Oral Oncol 2006;42:96-101.
6. Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y. Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: Results of a randomized clinical trial. Cancer 1980;46:386-90.
7. Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391-4.
8. Lim YC, Lee JS, Koo BS, Kim SH, Kim YH, Choi EC. Treatment of contralateral NO neck in early squamous cell carcinoma of the oral tongue: Elective neck dissection versus observatiorr. Laryngoscope 2006; 116:461-5.
9. Teichgraeber JF, Clairmont AA. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: Treatment rationale. Head Neck Surg 1984;7:15-21.
10. Whitehurst JO, Droulias CA. Surgical treatment of squamous cell carcinoma of the oral tongue: Factors influencing survival. Arch Otolaryngol 1977;103:212-5.
11. Yuen AP, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997;19:583-8.
12. Dias FL, Kligerman J, Matos de Sá G, Arcuri RA, Freitas EQ, Farias T. Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001;125:23-9.
13. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989;158:309-13.
14. Pillsbury HC, Clark M. A rationale for therapy of the NO neck. Laryngoscope 1997;107:1294-315.
15. Wei WI, Ferlito A, Rinaldo A, Gourin CG, Lowry J, Ho WK. Management of the NO neck - reference or preference. Oral Oncol 2006;42:115-22.
16. Brazilian Head and Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 1998;176:422-7.
17. Ferlito A, Mannara GM, Rinaldo A, Politi M, Robiony M, Costa F. Is extended selective supraomohyoid neck dissection indicated for treatment of oral cancer with clinically negative neck? Acta Otolaryngol 2000;120:792-5.
18. Hutter RVP, Greene FL, Balch CM, Page DL, Haller DG, Fleming ID. AJCC Cancer Staging Manual. 6th edn. New York: Springer-Verlag 2002,23-32.
19. Werner JA, Dünne AA, Myers JN. Functional anatomy of the lymphatic drainage system of the upper aerodigcstive tract and its role in metastasis of squamous cell carcinoma. Head Neck 2003:25:322-32.
20. Nieuwenhuis EJ, Castelijns JA, Pijpers R, van der Brekel MW, Brakenhoff RH, van der Waal I, et al. Wait-and-sce policy for the NO neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: Is there a role for identification of the sentinel node? Head Neck 2002;24:282-9.
21. Byers RM, Weber RS, Andrews T, McGill D, Kate R, WolfP. Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck 1997:19:14-9.
22. Spaulding CA, Korb LJ, Constable WC, Cantrell RW, Levine PA. The influence of extent of neck treatment upon control of cervical lymphadenopathy in cancers of the oral tongue. Int J Radiat Oncol Biol Phys 1991;21:577-81.
23. White D, Byers RM. What is the preferred initial method of treatment for squamous carcinoma of the tongue? Am J Surg 1980;140:553-5.
24. Wendt CD, Peters U, Delclos L, Ang KK, Morrison WH, Maor MH. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of thempy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys 1990;18:1287-92.
25. Chow JM, Levin BC, Krivit JS, Applebaum FL. Radiotherapy or surgery for subclinical cervical node metastases. Arch Otolaryngol Head Neck Surg 1989; 115:981-4.